WCM Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-48,199
| Closed | -$4.19M | – | 211 |
|
|
2021
Q3 | $4.19M | Buy |
48,199
+236
| +0.5% | +$20.5K | 0.01% | 149 |
|
|
2021
Q2 | $3.93M | Buy |
47,963
+1,755
| +4% | +$144K | 0.01% | 145 |
|
|
2021
Q1 | $4.4M | Sell |
46,208
-62,225
| -57% | -$5.92M | 0.01% | 140 |
|
|
2020
Q4 | $6.73M | Buy |
108,433
+46,225
| +74% | +$2.87M | 0.02% | 133 |
|
|
2020
Q3 | $3.7M | Buy |
62,208
+3,886
| +7% | +$231K | 0.01% | 144 |
|
|
2020
Q2 | $4.07M | Buy |
58,322
+4,740
| +9% | +$331K | 0.02% | 136 |
|
|
2020
Q1 | $2.43M | Buy |
53,582
+15,355
| +40% | +$697K | 0.01% | 144 |
|
|
2019
Q4 | $2.49M | Buy |
38,227
+28,880
| +309% | +$1.88M | 0.01% | 140 |
|
|
2019
Q3 | $580K | Hold |
9,347
| – | – | ﹤0.01% | 139 |
|
|
2019
Q2 | $666K | Buy |
9,347
+4,772
| +104% | +$340K | ﹤0.01% | 138 |
|
|
2019
Q1 | $359K | Buy |
+4,575
| New | +$359K | ﹤0.01% | 138 |
|